Global News

Develop a patient recruitment strategy the right way

Monday, July 25, 2016

The Pulse on Patient Recruitment by Ashley Tointon

When recruiting patients for clinical trials, multiple things can go wrong. The majority of us have likely encountered at least one horror story involving huge patient recruitment budgets that resulted in miniscule measurable results. These pervasive stories enable the continuation of a commonly held feeling of skepticism about the value of patient recruitment services. The “when things go wrong” story is passé and should be replaced with the “when things go right” story. One of the best ways to ensure patient recruitment success is to set up the program correctly from the start.

[Read More]

Evoke Pharma issues topline results from EVK-001 phase III trial

Thursday, July 21, 2016

Evoke Pharma, a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, has announced topline results from its phase III clinical trial of EVK-001 in female patients with symptomatic diabetic gastroparesis. In this study, EVK-001, the company’s patented nasal delivery formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult women, did not achieve its primary endpoint of symptom improvement at Week 4.

[Read More]

Certara appoints Nathan Teuscher to lead Phoenix Software Division

Thursday, July 21, 2016

Certara, a provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, has announced the appointment of Nathan Teuscher, Ph.D., to vice president of pharmacometric solutions. In his new role, Dr. Teuscher will lead the company’s Phoenix software division. He previously served as Certara’s vice president of scientific training.

[Read More]

CEO George Scangos to leave Biogen

Thursday, July 21, 2016

Biogen has announced that George Scangos, its chief executive officer, will be leaving the company in the coming months after a successor has been identified. The company will begin a search for his successor immediately.

[Read More]

Novella hires three new executives

Thursday, July 21, 2016

Three new team members have joined Novella Clinical. Fiona Markwood is Novella’s new executive vice president of Oncology Project Management; Anusha Bala, BSc, LLB, is Novella’s new global head of Regulatory Affairs; and Joy Yucaitis joins Novella as senior director of Oncology Strategy.

[Read More]